0001209191-21-051528.txt : 20210816
0001209191-21-051528.hdr.sgml : 20210816
20210816092417
ACCESSION NUMBER: 0001209191-21-051528
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210812
FILED AS OF DATE: 20210816
DATE AS OF CHANGE: 20210816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: de Kruif John
CENTRAL INDEX KEY: 0001790353
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37773
FILM NUMBER: 211174961
MAIL ADDRESS:
STREET 1: C/O MERUS N.V.
STREET 2: YALELAAN 62
CITY: UTRECHT
STATE: P7
ZIP: 3584 CM
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merus N.V.
CENTRAL INDEX KEY: 0001651311
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: YALELAAN 62
CITY: 3584 CM UTRECHT
STATE: P7
ZIP: 3584 CM
BUSINESS PHONE: 31 030 253 8800
MAIL ADDRESS:
STREET 1: YALELAAN 62
CITY: 3584 CM UTRECHT
STATE: P7
ZIP: 3584 CM
FORMER COMPANY:
FORMER CONFORMED NAME: Merus B.V.
DATE OF NAME CHANGE: 20150819
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-12
0
0001651311
Merus N.V.
MRUS
0001790353
de Kruif John
C/O MERUS N.V.
YALELAAN 62
UTRECHT
P7
3584 CM
NETHERLANDS
0
1
0
0
SVP & Chief Technology Officer
Common Shares
2021-08-12
4
M
0
3333
A
15830
D
Common Shares
2021-08-12
4
M
0
2239
A
18069
D
Common Shares
2021-08-12
4
S
0
2787
19.34
D
15282
D
Share Option (right to buy)
2021-08-12
4
M
0
3333
0.00
D
2022-06-17
Common Shares
3333
0
D
Share Option (right to buy)
2021-08-12
4
M
0
2239
0.00
D
2023-03-16
Common Shares
2239
0
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan.
Exercise price is denominated in Euros at 1.93.
Amount represents the weighted average price of shares sold, which ranged from $19.20 to $19.425. Details of individual transactions are available upon request.
These options are fully vested.
Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on June 17, 2014.
Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on March 16, 2015.
/s/ Peter Silverman as attorney-in-fact
2021-08-16